8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study

Bioeffects Seen

Authors not listed · 2013

Share:

Therapeutic magnetic stimulation improved Alzheimer's cognition, showing EMF effects depend on precise application rather than blanket exposure.

Plain English Summary

Summary written for general audiences

Israeli researchers tested repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training on 15 Alzheimer's patients in a double-blind study. The treatment group showed significant cognitive improvements (3.76 points on ADAS-cog scale) after 6 weeks compared to placebo, with benefits lasting 4.5 months. This suggests targeted magnetic fields may help restore brain function in dementia patients.

Why This Matters

This study represents a fascinating paradox in EMF research. While we consistently document harmful effects from chronic, low-level electromagnetic exposures from phones and wireless devices, here we see therapeutic magnetic stimulation actually improving brain function in Alzheimer's patients. The key difference lies in the approach: therapeutic rTMS uses precisely controlled, targeted magnetic pulses to stimulate specific brain regions, rather than the chaotic, continuous radiation that saturates our daily environment. What this means for you is that EMF effects depend entirely on frequency, intensity, duration, and biological target. The same electromagnetic principles that can damage healthy tissue through chronic exposure can potentially heal when applied therapeutically under medical supervision. This doesn't diminish concerns about everyday EMF exposure, but it does highlight the complexity of electromagnetic bioeffects and the importance of distinguishing between therapeutic applications and environmental pollution.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2013). Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study.
Show BibTeX
@article{repetitive_transcranial_magnetic_stimulation_combined_with_cognitive_training_is_a_safe_and_effective_modality_for_the_treatment_of_alzheimers_disease_a_randomized_double_blind_study_ce4513,
  author = {Unknown},
  title = {Repetitive transcranial magnetic stimulation combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: a randomized, double-blind study},
  year = {2013},
  doi = {10.1007/s00702-012-0902-z},
  
}

Quick Questions About This Study

Yes, this study found repetitive transcranial magnetic stimulation combined with cognitive training improved ADAS-cog scores by 3.76 points after 6 weeks, significantly better than placebo. Benefits persisted for 4.5 months of treatment.
Therapeutic rTMS uses precisely controlled magnetic pulses targeted at specific brain regions under medical supervision. This contrasts sharply with chaotic, continuous electromagnetic radiation from phones and wireless devices that saturates our environment.
Patients received 1-hour daily rTMS sessions five days per week for 6 weeks, followed by biweekly maintenance sessions for 3 months. The study used the NeuroAD system combining stimulation with cognitive training.
The researchers reported the NeuroAD rTMS system was safe with no significant adverse effects mentioned in this 15-patient study. However, this was a small trial requiring larger studies for comprehensive safety assessment.
After 6 weeks, the treatment group improved 3.76 points on ADAS-cog while placebo improved only 0.47 points. At 4.5 months, treated patients maintained 3.52-point improvement while placebo patients worsened by 0.38 points.